D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons

Angulo, 1990, Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat, J. Neurochem., 54, 1889, 10.1111/j.1471-4159.1990.tb04887.x

Angulo, 1986, Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA, Eur. J. Pharmacol., 130, 341, 10.1016/0014-2999(86)90290-6

Bannon, 1987, Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonist and antagonists, Mol. Brain Res., 3, 31, 10.1016/0169-328X(87)90041-6

Brumlik, 1964, A critical analysis of the effects of trihexyphenidyl (artane) on the components of the parkinsonian syndrome, J. Nerv. Ment. Dis., 138, 424, 10.1097/00005053-196405000-00002

Burns, 1964, Effects of trihexyphenidyl hydrochloride (artane) on Parkinson's disease, Neurology, 14, 13, 10.1212/WNL.14.1.13

Butkerait, 1988, Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390, Eur. J. Pharmacol., 148, 269, 10.1016/0014-2999(88)90573-0

Carvey, 1986, The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity, Eur. J. Pharmacol., 120, 193, 10.1016/0014-2999(86)90540-6

Chirgwin, 1979, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18, 5294, 10.1021/bi00591a005

Church, 1984, Genomic sequencing, 81, 1991

Cotzias, 1967, Aromatic amino acids and modificatio of parkinsonism, N. Engl. J. Med., 276, 374, 10.1056/NEJM196702162760703

Cotzias, 1969, Modification of parkinsonism — chronic treatment with l-dopa, N. Engl. J. Med., 280, 337, 10.1056/NEJM196902132800701

Cruz, 1989, Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra, Neuroscience, 30, 331, 10.1016/0306-4522(89)90257-1

Cuello, 1978, Evidence for a long leu-enkephalin striatopallidal pathway in rat brain, Nature, 271, 178, 10.1038/271178a0

Difiglia, 1982, Light and electron microscopic localization of immunoreactive leu-enkephalin in monkey basal ganglia, J. Neurosci., 2, 303, 10.1523/JNEUROSCI.02-03-00303.1982

Gerfen, 1990, D1 and D2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons, Science, 250, 1429, 10.1126/science.2147780

Gerfen, 1988, Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study, Brain Res., 460, 161, 10.1016/0006-8993(88)91217-6

Hall, 1985, Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain, Eur J. Pharmacol., 111, 191, 10.1016/0014-2999(85)90756-3

Hamlin, 1957, Current concepts in therapy, 256, 699

Harrison, 1990, Selective localization of striatal D1 receptors to striatonigral neurons, Brain Res., 528, 317, 10.1016/0006-8993(90)91674-6

Hong, 1980, Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons, Adv. Biochem. Psychopharmacol., 24, 223

Jessel, 1978, Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study, Brain Res., 152, 487, 10.1016/0006-8993(78)91104-6

Lehmann, 1983, The striatal cholinergic interneurons: synaptic target of dopaminergic terminals?, Neuroscience, 10, 1105, 10.1016/0306-4522(83)90102-1

Lemischka, 1981, Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA, J. Mol. Biol., 151, 101, 10.1016/0022-2836(81)90223-0

Le Moine, 1990, Dopamine receptor gene expression by enkephalin neurons in the rat forebrain, 87, 230

Le Moine, 1990, D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum, Neurosci. Lett., 117, 248, 10.1016/0304-3940(90)90671-U

Mocchetti, 1987, Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes, J. Pharmacol Exp. Ther., 241, 1120

Morris, 1988, Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists, Neuroscience, 25, 525, 10.1016/0306-4522(88)90256-4

Normand, 1987, Anatomical study of enkephalin gene expression in the rat forebrain following haloperidol treatment, Neurosci. Lett., 83, 232, 10.1016/0304-3940(87)90091-7

Ogren, 1988, D1 and D2 receptor antagonists induce catalepsy via different efferent striatal pathways, Neurosci. Lett., 85, 333, 10.1016/0304-3940(88)90588-5

Pickel, 1990, Spiny neurons lacking choline acetyltransferase immunoreactivity are major targets of cholinergic and catecholaminergic terminals in the rat striatum, J. Neurosci., 25, 263, 10.1002/jnr.490250302

Pollack, 1989, Modulation of striatal preproenkephalin mRNA levels by the D2 dopamine receptor, Soc. Neurosci. Abstr., 15, 368

Romano, 1987, Haloperidol increases proenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization, Mol. Brain Res., 2, 33, 10.1016/0169-328X(87)90018-0

Stoof, 1982, Stimulation of D2-dopamine receptors in the rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin, Eur. J. Pharmacol., 84, 211, 10.1016/0014-2999(82)90204-7

Stoof, 1987, Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation, Brain Res., 423, 364, 10.1016/0006-8993(87)90864-X

Tang, 1983, Increases in proenkephalin mRNA and enkephalin content of the rat striatum after daily injection of haloperidol for 2 to 3 weeks, 80, 3841

Thal, 1983, Striatal met-enkephalin concentration increases following nigrostriatal denervation, Biochem. Pharmacol., 32, 3297, 10.1016/0006-2952(83)90353-2

Thomas, 1983, Hybridization of denatured RNA transferred or dotted to nitrocellulose paper, Methods Enzymol., 100, 255, 10.1016/0076-6879(83)00060-9

Trugman, 1987, Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions, J. Neurosci., 7, 2927, 10.1523/JNEUROSCI.07-09-02927.1987

Weiner, 1990, Expression of muscarinic acetylcholine and dopamine receptor mRNAs in the rat basal ganglia, 87, 7050

Young, 1986, Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain, 83, 9827